Approaches to combination chemotherapy in rat, mouse, and hamster tumors.
D000230:Adenocarcinoma / Q000139:chemically induced / Q000188:drug therapy*; D000577:Amides / Q000627:therapeutic use; D000732:Androstanols / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006224:Cricetinae; D003510:Cyclohexanes / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004958:Estradiol / Q000627:therapeutic use; D005260:Female; D006918:Hydroxyurea / Q000627:therapeutic use; D007093:Imidazoles / Q000627:therapeutic use; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000188:drug therapy*; D008545:Melanoma / Q000188:drug therapy*; D008558:Melphalan / Q000627:therapeutic use; D051379:Mice; D008809:Mice, Inbred C3H; D008815:Mice, Inbred Strains; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy; D012516:Osteosarcoma / Q000188:drug therapy*; D010954:Plasmacytoma / Q000188:drug therapy*; D011374:Progesterone / Q000627:therapeutic use; D051381:Rats; D012513:Sarcoma, Experimental / Q000188:drug therapy; D014226:Triazenes / Q000627:therapeutic use
D000577:Amides; D000732:Androstanols; D000970:Antineoplastic Agents; D003510:Cyclohexanes; D007093:Imidazoles; D014226:Triazenes; D003561:Cytarabine; D011374:Progesterone; D004958:Estradiol; D004317:Doxorubicin; D003520:Cyclophosphamide; D008558:Melphalan; D006918:Hydroxyurea